Tevogen Bio Warrant (TVGNW)

• Market cap: $6.79M
• 1 day: 0%
• 5 days: 5.43%
• 1 month: -13.79%
• 3 months: -16.7%
• 6 months: -37.14%
• Year to date: -11.93%
• 1 year: -36.16%
• 5 years: -91.8%
• 10 years: -91.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17